Search

everythinglearnresearchcommunity

for

Search:↓

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Researchers found a new way to isolate sweat glands from the scalp for study and culture.

A man developed alopecia areata after starting cancer treatment with vandetanib.

The book is a valuable resource for understanding hair and scalp problems but could be updated with more information on certain conditions.

Enemas can cause septicemia in elderly men with prostate infections.

Artificial hair fibers help treat scalp scars with few complications and a 20% yearly fiber fall rate.

Fiber implants effectively treat permanent hair loss with few complications.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Scalp hair follicle culture has limits for testing minoxidil's hair growth effects.

Abnormal scalp whorls can indicate brain development issues but may also be seen in neurologically normal people.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Micropigmentation safely and effectively hides scalp hair loss and scars.

Minoxidil didn't increase scalp blood flow for hair growth, but hexyl nicotinate did.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Grouping certain skin cells together activates a growth pathway that helps create new hair follicles.